Sometimes the parts are worth more than the whole. That’s the case with Exor, whose massive discount has created a low-risk bet for value-seeking investors.
Analysts cut 2025 and 2026 EPS estimates after Stellantis skipped a 2025 payout, but they still kept a Buy rating and a €124 target. This stings more than it used to because Exor is now an “investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results